Hubei's R & D of traditional Chinese medicine has achieved remarkable results, and 20% of new drugs have been approved nationwide

On March 27, good news came from the food and Drug Administration of Hubei Province In 2011, 21 new Chinese medicine drugs were approved nationwide, including 4 in Hubei Province, accounting for 19% Among the four approved new drugs, there are not only the excavation and inheritance of excellent traditional Chinese medicine, such as Banxia Hewei Granules of Wuhan Fuxing biopharmaceutical Co., Ltd., Xiaoer Yima granules of Wuhan Jianmin Pharmaceutical Co., Ltd., Huaiyu Qingre Zhixue Capsule of Ma Yinglong Pharmaceutical Group Co., Ltd., but also the breakthrough of modern Chinese medicine extraction technology, such as Wuhan United Pharmaceutical Co., Ltd Company's valerian extract capsules It has added new impetus to realize the healthy and rapid development of medical economy in Hubei Province In order to help enterprises deeply understand the new connotation and new ideas of the state on the registration of traditional Chinese medicine, Hubei food and drug administration has repeatedly invited national experts on the registration of traditional Chinese medicine to make academic reports, and led enterprises to participate in symposiums on the research and development of traditional Chinese medicine and registration management organized by the state, so as to build a communication and exchange platform between enterprises and regulatory approval and authoritative departments to help enterprises solve the problem Difficulties and problems in R & D registration We will intervene in the development of traditional Chinese medicine varieties of excellent enterprises in advance, follow up the whole process, and provide all-round policy guidance and communication services Through the efforts, the research and development of new traditional Chinese medicine in Hubei Province is not only considerable in quantity, but also good in quality.